Back

WHO Should Bear The Cost Of COVID-19 Non-Vaccination? A Luck Egalitarian Assessment In A South African Insured Population

Solanki, G.; Little, F.; cleary, s.

2026-07-10 public and global health
10.64898/2026.07.07.26357455 medRxiv
Show abstract

Background Personal choice in health behaviours raises difficult questions: when individuals freely decline effective preventive interventions, who should bear the resulting costs? This tension is acute in insurance systems where resources are pooled, yet all health systems pursuing Universal Health Coverage must navigate the boundary between collective solidarity and individual accountability. During the COVID-19 pandemic, vaccines were freely available to members of South African private medical schemes, creating conditions in which non-vaccination could plausibly be examined as a matter of personal choice rather than constrained access. This study applied a luck egalitarian framework to assess whether non-vaccination reflected personal choice or constrained circumstance, and to quantify resulting excess costs. Methods A contextual review assessed barriers to vaccination. Using de-identified claims data for approximately 550,000 individuals (March 2020 to December 2022), logistic regression estimated each person's predicted probability of vaccination based on demographic and clinical factors, with observed and predicted rates compared across strata to infer choice versus circumstance. A zero-inflated negative binomial model estimated predicted expenditure among vaccinated members, applied to the full population to simulate universal vaccination. Excess costs were calculated across predicted probability strata. Results Predicted and observed vaccination rates were closely aligned, suggesting that residual non-vaccination in higher-probability groups reflected personal choice rather than constrained circumstance. Observed costs exceeded predicted costs by 22% under universal vaccination, concentrated among older adults and those with comorbidities. Among those with a 60 to 70% predicted probability of vaccination, observed costs exceeded predicted costs by 127.6%. In contrast, among younger, low-risk members, predicted costs slightly exceeded observed expenditure, as vaccination costs were not offset by reduced hospitalisation. Conclusion Risk pooling depends on solidarity, yet non-vaccination due to personal choice shifts costs in ways that challenge fairness in community-rated insurance. These findings highlight the need for transparent deliberation about when personal responsibility should inform equitable health financing design.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 14%
13.0%
2
PLOS Global Public Health
344 papers in training set
Top 1%
12.6%
3
Social Science & Medicine
17 papers in training set
Top 0.1%
7.9%
4
BMC Health Services Research
51 papers in training set
Top 0.3%
6.8%
5
BMC Public Health
158 papers in training set
Top 0.7%
5.5%
6
Vaccine
203 papers in training set
Top 0.7%
4.4%
50% of probability mass above
7
BMJ Global Health
113 papers in training set
Top 1.0%
4.1%
8
BMJ Open
601 papers in training set
Top 8%
2.4%
9
Journal of Epidemiology and Community Health
34 papers in training set
Top 0.2%
2.4%
10
The Lancet Public Health
20 papers in training set
Top 0.1%
2.0%
11
BMC Medicine
176 papers in training set
Top 2%
1.9%
12
Health Policy
11 papers in training set
Top 0.3%
1.7%
13
American Journal of Epidemiology
67 papers in training set
Top 0.6%
1.7%
14
Epidemics
116 papers in training set
Top 1%
1.7%
15
Frontiers in Public Health
148 papers in training set
Top 4%
1.7%
16
BMJ Public Health
25 papers in training set
Top 0.8%
1.3%
17
Journal of Public Health
24 papers in training set
Top 0.8%
1.1%
18
PLOS Digital Health
106 papers in training set
Top 3%
1.0%
19
eLife
5828 papers in training set
Top 60%
1.0%
20
PLOS Medicine
110 papers in training set
Top 3%
1.0%
21
Global Health Action
10 papers in training set
Top 0.5%
0.9%
22
Journal of Global Health
21 papers in training set
Top 1.0%
0.9%
23
BMC Infectious Diseases
133 papers in training set
Top 4%
0.9%
24
Health Expectations
14 papers in training set
Top 0.6%
0.9%
25
Nature Communications
5641 papers in training set
Top 56%
0.9%
26
Health & Place
10 papers in training set
Top 0.4%
0.6%
27
The Lancet Healthy Longevity
11 papers in training set
Top 0.2%
0.6%
28
The Lancet Infectious Diseases
73 papers in training set
Top 1%
0.6%
29
BMC Geriatrics
18 papers in training set
Top 0.5%
0.6%